<scp>FGF</scp>23 is associated with disease severity and prognosis in chronic heart failure

Abstract

The phosphatonin FGF23 is strongly associated with disease severity and long-term outcome in patients with nonischaemic heart failure and preserved renal function. Further studies are needed to evaluate the pathophysiologic role of FGF23 and its potential as a biomarker in heart failure.